Health ❯ Healthcare ❯ Medical Research

Cancer Research

Immunotherapy Breast Cancer Pancreatic Cancer Prostate Cancer Colorectal Cancer Glioblastoma Ovarian Cancer Multiple Myeloma Vaccine Development Clinical Trials

Bloomberg Leads 2025 Philanthropy 50 as Transparency Rules Exclude MacKenzie Scott

The ranking reflects strict verification of donor‑advised funds that can leave major givers off the list.

Severe COVID or Flu Tied to Higher Future Lung Cancer Risk, UVA Study Finds

New RNA Splicing Readout Charts Cancer-Wide Programs, Points to About 120 Potential Targets

AI Tools Boost Breast Cancer Detection in NHS Studies, Cutting Reading Workloads

CD70-Targeted HIT Cells Eradicate Solid Tumors in Mice

Waterloo Scientists Ready Engineered Tumor‑Eating Bacteria for Preclinical Testing

Microplastics Detected in Prostate Tumors in Small NYU Study

Mayo Clinic Upgrades Orchestrate With OMOP Oncology to Standardize Cancer Data

NCI Pursues Preclinical Test of Ivermectin’s Anti-Cancer Activity

CNIO’s Triple-Drug Mouse Breakthrough on Pancreatic Cancer Moves Into a Cautious Preclinical Phase

Triple Therapy Eradicates Pancreatic Tumors in Mice in CNIO Study

Four-Marker Blood Test Shows About 92% Accuracy for Early Pancreatic Cancer in Retrospective Study

NIH-Supported Study Unveils Four-Marker Blood Test for Earlier Detection of Pancreatic Cancer

Spanish Team Eradicates Pancreatic Tumors in Mice With Triple-Drug Regimen, PNAS Study Finds

Aspirin Started After 70 Fails to Prevent Cancer, Shows Higher Cancer Deaths During Trial

Triple-Drug Strategy Wipes Out Pancreatic Tumors in Mice, Study Finds

New CAR T Strategy Targets Tumor Macrophages, Triggers Antitumor Immunity in Mice

Preclinical Study Flags NPM1 as Potential Target in Some Bowel and Liver Cancers

Low CTDNEP1 Tied to Poorer Outcomes in Pancreatic Cancer, Study Finds

Immune Atlas Sharpens Myeloma Risk Prediction as Dual-Target CAR T Counters BCMA Loss